Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Received: 10 July 2018
Accepted: 12 March 2019
First Online: 28 March 2019
Ethics approval and consent to participate
: All study materials were approved by the New England Independent Review Board (NEIRB#: 16–168). Patients provided their written informed consent prior to responding to the survey questions.
: All authors have reviewed the final manuscript and approve the submission. Identifying images, personal details, and clinical details of patient participants are not presented, therefore consent to publish from patient participants is not applicable.
: Dr. Huynh, Ms. Bhak, Mr. Narkhede, Mr. Totev, and Dr. Duh are employees of Analysis Group, Inc., a consulting company that has received research funds from Novartis Pharmaceuticals Corporation. Dr. Neary and Dr. Cai are employees of Novartis Pharmaceuticals Corporation. Ms. Beaumont, Dr. Halperin and Dr. Cella have received consulting fees from Novartis Pharmaceuticals Corporation.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.